SEC Form 4 · accession 0001162194-18-000016
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerhard F Burbach
Director
Period of report
Feb 13, 2018
Accepted (ET)
Feb 15, 2018 · 5:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 13, 2018 | A | 8,597 | $0.00 | A | 24,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2018. The Reporting Person has deferred settlement of the Restricted Stock Units to occur within the thirty (30) day period immediately following the earlier to occur of (i) the Reporting Person's termination of service with the Issuer; and (ii) a Change of Control (as defined in the Company's 2011 Equity Incentive Plan).
- F2Includes an aggregate of 19,115 vested Restricted Stock Units for which the Reporting Person has deferred settlement as described above.